Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-10

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva’s generic levothyroxine sodium product under an Original Application (ANDA 207588).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)